NASDAQ
No price data available for this timeframe.
Immunocore Holdings plc (IMCR) has a free cash flow growth of 56.30% as of Friday, May 29, 2026. This represents a 98.75% decrease compared to its 12-month average of 4486.80%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.